Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Aydin Mirzaee is CEO of Fellow AI, a meeting and note-taking assistant.
Coalition argues Council’s changes would increase complexity, costs, and administrative burdens, impeding EU innovation and competitiveness.
A practical guide on the impact of advanced AI such as Mythos on business functions, from cybersecurity to legal to AI governance to risk to the board.
As regulators move from trialling AI to active oversight, firms face pressure to build governance structures to withstand scrutiny across multiple jurisdictions.
Privacy KPIs that are aligned with strategy are better positioned to manage risk and demonstrate that their programs are effective, credible, and fit for purpose.
Data security and operational resilience top of mind as boards enter AI era.
A security checklist for regulated Industries.